

![]() |
Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors |
|
Authors | ![]() | |
Published in | Journal of acquired immune deficiency syndromes. 2011, vol. 57, no. 1, p. 24-31 | |
Abstract | Nucleoside reverse transcriptase inhibitors (NRTIs) are often administered in salvage therapy even if genotypic resistance tests (GRTs) indicate high-level resistance, but little is known about the benefit of these additional NRTIs. | |
Keywords | Adult — Anti-HIV Agents/administration & dosage — Cohort Studies — Female — HIV Infections/blood/drug therapy/virology — HIV-1/growth & development — Humans — Logistic Models — Male — Middle Aged — Proportional Hazards Models — Pyrrolidinones/administration & dosage — RNA, Viral/blood — Reverse Transcriptase Inhibitors/administration & dosage — Salvage Therapy/methods | |
Identifiers | PMID: 21283013 | |
Full text | ||
Structures | ||
Research groups | Groupe Laurent Kaiser (virologie clinique) (668) Unité HIV (46) | |
Citation (ISO format) | SCHERRER, Alexandra U et al. Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors. In: Journal of acquired immune deficiency syndromes, 2011, vol. 57, n° 1, p. 24-31. doi: 10.1097/QAI.0b013e318211925e https://archive-ouverte.unige.ch/unige:25321 |